Clonidine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

29 Suppliers, 19 USDMF, 5 CEP/COS, 3 EU WC, 17 NDC API, 11 Listed Suppliers

DEVELOPMENTS

10 Drug(s) in Development

10 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

173 Dossiers, 120 FDA Orange Book, 13 Europe, 14 Canada, 8 Australia, 4 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 30 Kerry, 25 Roquette, 21 BASF, 13 Seppic, 12 Sigachi Industries, 12 Microlex e.U, 12 Gangwal Chemicals, 11 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 Gangwal Healthcare, 9 Actylis, 8 Boai NKY Pharmaceuticals Ltd, 6 DFE Pharma, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 DKSH, 5 Ideal Cures Pvt Ltd, 5 SPI Pharma, 4 Prachin Chemical, 4 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 4 Pharmatrans-Sanaq, 3 Nanjing Well Pharmaceutical, 3 Ulanqab Kema New Material, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Jai Radhe Sales, 2 Rochem International Inc, 1 Aeon Procare, 1 Pharm-RX Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Clariant, 1 Pfanstiehl, 1 Nanjing Bold Chemical, 1 ACG Worldwide, 1 Qualicaps, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 42 Disintegrants & Superdisintegrants, 37 Direct Compression, 27 Granulation, 25 Controlled & Modified Release, 23 Solubilizers, 23 Thickeners and Stabilizers, 17 Lubricants & Glidants, 16 Taste Masking, 14 Parenteral, 14 Co-Processed Excipients, 11 Film Formers & Plasticizers, 10 Chewable & Orodispersible Aids, 8 Topical, 7 Emulsifying Agents, 7 API Stability Enhancers, 6 Rheology Modifiers, 5 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 2 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 17 Finished Drug Prices

MARKET PLACE

9 APIs, 3 DOSSIERS // FDF

PATENTS

6 US Patents

6 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

DIGITAL CONTENT

3 Data Compilation & Company Tracker #PharmaFlow, 33 News, 1 Monthly Stock Recap #PipelineProspector

Information, Expiry & Status of FDA Orange Book Patents covering Clonidine

Clonidine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

29 Suppliers

19 USDMF

5 CEP/COS

3 EU WC

17 NDC API

11 Listed Suppliers

DEVELOPMENTS

10 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

173 Dossiers

120 FDA Orange Book

13 Europe

14 Canada

8 Australia

4 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

30 Kerry

25 Roquette

21 BASF

13 Seppic

12 Sigachi Industries

12 Microlex e.U

12 Gangwal Chemicals

11 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Gangwal Healthcare

9 Actylis

8 Boai NKY Pharmaceuticals Ltd

6 DFE Pharma

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 DKSH

5 Ideal Cures Pvt Ltd

5 SPI Pharma

4 Prachin Chemical

4 Ingredion Pharma Solutions

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

3 Nanjing Well Pharmaceutical

3 Ulanqab Kema New Material

3 Kima Chemical

2 The Dow Chemical Company

2 Jai Radhe Sales

2 Rochem International Inc

1 Aeon Procare

1 Pharm-RX Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

1 Clariant

1 Pfanstiehl

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Qualicaps

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders

47 Coating Systems & Additives

42 Disintegrants & Superdisintegrants

37 Direct Compression

27 Granulation

25 Controlled & Modified Release

TABLET;ORAL - 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons